This donation will help all people that suffer from cancer, as well as all their relatives and friends, that make them company during their experience.
When scientist Bill E. Cham heard how australian farmers treated their cattle's skin cancer by applying eggplant extracts to the animal's lesion, he started researching about the plant's potential. After more than 30 years of dedication, Bill developed an active compound which he named BEC, extracted from the eggpplant family of plants. This "natural" active compound BEC treats skin cancer in humans in just a couple of weeks by attacking cancerous cells and leaving all other cells intact. It has no systemic side effects and its profoundness assures the cancer wont re-appear.
BEC's results are so profound and precise that Dr. Bill Cham joined efforts with Dr. Gastón Cornu Labat to test BEC as treatment for other types of cancers.Initial results show that BEC effectively treats most types of cancers naturally and safely. All indicates that Bill and Gastón have found what in medicine is called a magic bullet, which is the meaning given to a unique solution that treats many diseases.
BEC was developed into a topical cream named Curaderm BCC to treat skin cancer in humans. Curaderm has been approved by European Health Authorities as medical device to be used in Europe and is being used as adjuvant to treat cancer naturally without the need of surgery nor treatments with systemic side effects.
Bill and Gaston have the dream of erradicating cancer from humans in a natural non-invasive affordable way, and they need to get Curaderm BCC/BEC approved as "drug" to then use BEC as a "safe" active component in the development of treatments for other types of cancers. The 1º step in this journey is to get approval from an Ethics Committee to initiate a Phase IV Clinical Trial for Curaderm BCC/BEC. Successfully completing a Phase IV will allow Curaderm BCC/BEC be approved as drug. Once such step is reached, then the next step of the journey will commence, the trials of different treatments based on BEC on most types of huma cancers.
The process of getting approved by an Ethics Committee to initiate a Phase IV Clinical Trial costs €12,000, out of which €4,000 is paid to a European Healthcare Authority (in this case the Agencia Española de Medicamentos), € 2,000 as fee to the Ethics Committee itself, and € 6,000 to 2 dermatology clinics where the trials will be conducted.
We plan to give back to doners 1% of initial 100,000 unit sales of Curaderm BCC during the Phase IV Clinical Trial phase.
We believe we have found a magic bullet (BEC). Help us erradicate cancer from humanity.